Collection: Infusion and Injection

Lavoisier Sodium Chloride 0.9%  Solution for Infusion

TGA Section 19A approved medicine

Indication(s)
For extracellular fluid replacement and in the management of metabolic alkalosis in the presence of fluid loss, and for restoring or maintaining the concentration of sodium and chloride ions.

From the TGA -
"IV fluids are essential medicines used in hospitals for routine and critical care.
They are crucial for fluid replacement, resuscitation, and administering other medications directly into the bloodstream.
The shortage is particularly affecting multiple bag sizes of Sodium Chloride 0.9% (saline) and Compound Sodium Lactate (Hartmann’s solution) products.
The shortages are due to multiple factors including global supply limitations, unexpected increases in demand, and manufacturing issues.
To improve supply, we have approved multiple overseas-registered alternative saline fluids under section 19A of the Therapeutic Goods Act 1989.
We are continuing to prioritise evaluation of additional applications submitted under TGA Section 19A."
https://www.tga.gov.au/about-IV-fluids-shortages

Under TGA Section 19A, ToBe Healthcare has been able to arrange for supply of the following alternative product, registered and marketed in France, on a temporary basis:

• Lavoisier Sodium Chloride 0.9%, Solution for Infusion in Dual Access PVC Bag 100 mL / Case of 50 
• Lavoisier Sodium Chloride 0.9%, Solution for Infusion in Dual Access PP Bag 250 mL / Case of 20 
• Lavoisier Sodium Chloride 0.9%, Solution for Infusion in Dual Access PP Bag 500 mL / Case of 20 

Account and Guest Customers Welcome